Works matching IS 00071048 AND DT 2011 AND VI 152 AND IP 5

Results: 23
    1
    2
    3
    4

    The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 561, doi. 10.1111/j.1365-2141.2010.08549.x
    By:
    • Hill, Brian T.;
    • Rybicki, Lisa;
    • Bolwell, Brian J.;
    • Smith, Stephen;
    • Dean, Robert;
    • Kalaycio, Matt;
    • Pohlman, Brad;
    • Tench, Shawnda;
    • Sobecks, Ronald;
    • Andresen, Steven;
    • Copelan, Edward;
    • Sweetenham, John
    Publication type:
    Article
    5
    6

    Optimal management of β thalassaemia intermedia.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 512, doi. 10.1111/j.1365-2141.2010.08486.x
    By:
    • Taher, Ali T.;
    • Musallam, Khaled M.;
    • Cappellini, Maria Domenica;
    • Weatherall, David J.
    Publication type:
    Article
    7
    8
    9
    10

    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 600, doi. 10.1111/j.1365-2141.2010.08519.x
    By:
    • Eide, Marianne B.;
    • Lauritzsen, Grete F.;
    • Kvalheim, Gunnar;
    • Kolstad, Arne;
    • Fagerli, Unn M.;
    • Maisenhölder, Martin;
    • Østenstad, Bjørn;
    • Fluge, Øystein;
    • Delabie, Jan;
    • Aarset, Harald;
    • Liestøl, Knut;
    • Holte, Harald
    Publication type:
    Article
    11

    Micromegakaryocytes in CSF.

    Published in:
    2011
    By:
    • Ramachandran, Jeyaprakash;
    • Kelly, Richard;
    • Bowen, David;
    • Gilleece, Maria
    Publication type:
    Other
    12

    Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 551, doi. 10.1111/j.1365-2141.2010.08485.x
    By:
    • Gallamini, Andrea;
    • Patti, Caterina;
    • Viviani, Simonetta;
    • Rossi, Andrea;
    • Fiore, Francesca;
    • Di Raimondo, Francesco;
    • Cantonetti, Maria;
    • Stelitano, Caterina;
    • Feldman, Tatyana;
    • Gavarotti, Paolo;
    • Sorasio, Roberto;
    • Mulè, Antonino;
    • Leone, Monica;
    • Rambaldi, Alessandro;
    • Biggi, Alberto;
    • Barrington, Sally;
    • Fallanca, Federico;
    • Ficola, Umberto;
    • Chauvie, Stéphane;
    • Gianni, Alessandro Massimo
    Publication type:
    Article
    13

    A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 570, doi. 10.1111/j.1365-2141.2010.08317.x
    By:
    • Hillmen, Peter;
    • Cohen, Dena R.;
    • Cocks, Kim;
    • Pettitt, Andrew;
    • Sayala, Hazem A.;
    • Rawstron, Andy C.;
    • Kennedy, Daniel B.;
    • Fegan, Christopher;
    • Milligan, Don W.;
    • Radford, John;
    • Mercieca, Jane;
    • Dearden, Claire;
    • Ezekwisili, Raphael;
    • Smith, Alexandra F.;
    • Brown, Julia;
    • Booth, Gillian A.;
    • Varghese, Abraham M.;
    • Pocock, Christopher
    Publication type:
    Article
    14

    Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 615, doi. 10.1111/j.1365-2141.2010.08532.x
    By:
    • Kuchinskaya, Ekaterina;
    • Heyman, Mats;
    • Nordgren, Ann;
    • Söderhäll, Stefan;
    • Forestier, Erik;
    • Wehner, Peder;
    • Vettenranta, Kim;
    • Jonsson, Olafur;
    • Wesenberg, Finn;
    • Sahlén, Sigrid;
    • Nordenskjöld, Magnus;
    • Blennow, Elisabeth
    Publication type:
    Article
    15
    16

    Evaluation of mutations in the isocitrate dehydrogenase genes in therapy-related and secondary acute myeloid leukaemia identifies a patient with clonal evolution to IDH2 R172K homozygosity due to uniparental disomy.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 669, doi. 10.1111/j.1365-2141.2010.08404.x
    By:
    • Pichler, Monika M.;
    • Bodner, Claudia;
    • Fischer, Carina;
    • Deutsch, Alexander J.;
    • Hiden, Karin;
    • Beham-Schmid, Christine;
    • Linkesch, Werner;
    • Guelly, Christian;
    • Sill, Heinz;
    • Wölfler, Albert
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: First results from the TRinity AntiPlatelet responsiveness (TrAP) study.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 640, doi. 10.1111/j.1365-2141.2010.08539.x
    By:
    • Tobin, William Oliver;
    • Kinsella, Justin A.;
    • Collins, Daniel Ronan;
    • Coughlan, Tara;
    • O'Neill, Desmond;
    • Egan, Bridget;
    • Tierney, Sean;
    • Feeley, Thomas Martin;
    • Murphy, Raymond P.;
    • McCabe, Dominick J. H.
    Publication type:
    Article